Discovery of a small molecule targeting SET-PP2A interaction to overcome BCR-ABLT315I mutation of chronic myeloid leukemia.

Oncotarget · 2015 · PMC4494927 · PMID 25900240

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Co-immunoprecipitation assay showed a trend of decrease on the association between SET and PP2A in K562 cells without significant alteration of SET expression in the presence of TGI1002 (Figure 4A ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.